Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ignatius Gerardo E. Zarraga"'
Autor:
Kazi T. Haq, PhD, Nichole M. Rogovoy, BS, Jason A. Thomas, BS, Christopher Hamilton, BA, Katherine J. Lutz, MD, Ashley Wirth, BS, Aron B. Bender, MD, David M. German, MD, MPH, Ryle Przybylowicz, MD, Peter van Dam, PhD, Thomas A. Dewland, MD, FHRS, Khidir Dalouk, MD, Eric Stecker, MD, FHRS, Babak Nazer, MD, Peter M. Jessel, MD, FHRS, Karen S. MacMurdy, MD, FHRS, Ignatius Gerardo E. Zarraga, MD, FHRS, Bassel Beitinjaneh, MD, Charles A. Henrikson, MD, MPH, FHRS, Merritt Raitt, MD, FHRS, Cristina Fuss, MD, Maros Ferencik, MD, PhD, MCR, Larisa G. Tereshchenko, MD, PhD, FHRS, CCDS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 4, Pp 374-381 (2021)
Background: Adaptive cardiac resynchronization therapy (aCRT) is known to have clinical benefits over conventional CRT, but the mechanisms are unclear. Objective: Compare effects of aCRT and conventional CRT on electrical dyssynchrony. Methods: A pro
Externí odkaz:
https://doaj.org/article/f75534ef16bc4200924a61e6d306a100
Autor:
Ryle Przybylowicz, Francis T. Phan, Ignatius Gerardo E. Zarraga, David J. Shim, Merritt H. Raitt, Peter M. Jessel
Publikováno v:
Heart Rhythm. 20:S539-S540
Autor:
Merritt H. Raitt, Ana Carolina Sauer Liberato, Cynthia M. Dougherty, Karen S. MacMurdy, Ignatius Gerardo E. Zarraga
Publikováno v:
Clinical Nursing Research. 31:588-597
To describe health related quality of life (HRQOL) and symptoms in the SPIRIT trial and determine effects of implantable cardioverter defibrillator (ICD) shocks on HRQOL over 24 months. Ninety participants aged 66 ± 10 years, 96% men, 75% with NYHA
Autor:
Jason Thomas, Ashley Wirth, Merritt H. Raitt, Khidir Dalouk, Maros Ferencik, Cristina Fuss, Ryle Przybylowicz, Katherine J. Lutz, Peter M. Jessel, Ignatius Gerardo E. Zarraga, Thomas A. Dewland, Larisa G. Tereshchenko, Charles A. Henrikson, Bassel Beitinjaneh, Nichole M. Rogovoy, Christopher Hamilton, Karen S. MacMurdy, Aron Bender, David M. German, Kazi T. Haq, Babak Nazer, Peter M. van Dam, Eric C. Stecker
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 4, Pp 374-381 (2021)
Heart Rhythm O2
Heart Rhythm O2
Background Adaptive cardiac resynchronization therapy (aCRT) is known to have clinical benefits over conventional CRT, but the mechanisms are unclear. Objective Compare effects of aCRT and conventional CRT on electrical dyssynchrony. Methods A prospe
Autor:
Francis Thanh Phan, Ryle Przybylowicz, Uday Gajjandra Sandhu, Christopher M. Verdick, Ignatius Gerardo E. Zarraga, Khidir Dalouk, Merritt H. Raitt, Peter M. Jessel
Publikováno v:
Heart Rhythm. 19:S176-S177
Autor:
Khidir Dalouk, Karen S. MacMurdy, Ignatius Gerardo E. Zarraga, Michael W. Gardner, Peter M. Jessel, Merritt H. Raitt, Miriam R. Elman, Mrinal Yadava
Publikováno v:
Journal of Cardiovascular Electrophysiology. 30:1636-1643
Dual external direct current cardioversion (dual-DCCV) is a rhythm control strategy for persistent atrial fibrillation (AF), involving simultaneous delivery of two shocks from two defibrillators. The long-term effectiveness of this approach has not b
Autor:
Eric C. Stecker, Peter M. van Dam, Ryle Przybylowicz, David M. German, Ashley Wirth, Charles A. Henrikson, Kazi T. Haq, Merritt H. Raitt, Katherine J. Lutz, Christopher Hamilton, Maros Ferencik, Thomas A. Dewland, Cristina Fuss, Babak Nazer, Ignatius Gerardo E. Zarraga, Karen S. MacMurdy, Aron Bender, Khidir Dalouk, Jason Thomas, Bassel Beitinjaneh, Nichole M. Rogovoy, Peter M. Jessel, Larisa G. Tereshchenko
IntroductionAdaptive cardiac resynchronization therapy (aCRT) is known to have clinical benefits over conventional CRT; however, their effects on the electrical dyssynchrony have not been compared.MethodsWe conducted a double-blind, randomized contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af8fefa9ffae1e19c0180f1669a2a686
https://doi.org/10.1101/2020.09.14.20194415
https://doi.org/10.1101/2020.09.14.20194415
Autor:
Merritt H. Raitt, Karen S. MacMurdy, Ignatius Gerardo E. Zarraga, Ana Carolina Sauer Liberato, Cynthia M. Dougherty
PurposeThe Spironolactone to Reduce ICD Therapy (SPIRIT) trial was designed to determine whether once daily spironolactone would: 1) reduce the incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF), and 2) improve health related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c4bf26ff25aee78f79d537d76ccf62d
https://doi.org/10.1101/2020.08.27.20016378
https://doi.org/10.1101/2020.08.27.20016378
Autor:
Babak Nazer, Kazi T. Haq, Ryle Przybylowicz, Merritt H. Raitt, Katherine J. Lutz, Christopher Hamilton, Ashley Wirth, Thomas A. Dewland, Khidir Dalouk, Charles A. Henrikson, Karen S. MacMurdy, Fuss Cristina, Ignatius Gerardo E. Zarraga, Jason Thomas, Aron Bender, Eric C. Stecker, Nichole M. Rogovoy, Peter M. van Dam, Peter M. Jessel, Bassel Beitinjaneh, David M. German, Ferencik Maros, Larisa G. Tereshchenko
Publikováno v:
Heart Rhythm. 18:S353
Autor:
Peter M. Jessel, Ignatius Gerardo E. Zarraga, Merritt H. Raitt, Cassandra Mullen, Christine Rutlen, Khidir Dalouk, Francis Phan, Karen S. MacMurdy
Publikováno v:
Heart Rhythm. 18:S336